• Generex Biotechnology Corporation (GNBT) Announces Mutual Decision Not to Proceed with Global Medical Direct Acquisition More... 

• Emergent BioSolutions (EBS) Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX Biopharma More...

• Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation (CC:CNJ) Worth US$61 Million Under Botulism Antitoxin Supply Contract More...

• Cellectis BioResearch and VitamFero Collaborate to Develop Vaccines against Parasitic Infection More... 

• Waters Corporation (WAT) and PREMIER Biosoft International Announce Collaboration for Advancing Lipidomics Research More...

 

• GTx, Inc. (GTXI) Announces Agreement with FDA on Phase III Clinical Development Plan Evaluating Ostarine(TM) (GTx-024) for the Prevention and Treatment of Muscle Wasting in Patients with Non-Small Cell Lung Cancer More... 

• Elite Pharmaceuticals, Inc. (ELI) Announces Manufacturing and Supply Agreement With Mikah Pharma, LLC More...

• AVI BioPharma, Inc. (AVII) Names Ed Kaye, M.D., Chief Medical Officer More... 

• FibroGen, Inc. Appoints R. Wayne Frost, Pharm.D., J.D., Vice President of Regulatory Affairs More...

• Bristol-Myers Squibb Company (BMY) Promotes Chad Ronholdt to VP of Strategic Development More... 

• Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations More... 

• Dr. David Kaplan Joins Kraig Biocraft Laboratories, Inc. Scientific Advisory Board More...

• Tikcro Technologies Reports 2011 First Quarter Results More...

• Johnson & Johnson (JNJ) Unit Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ordered to Pay Record Breaking $327 Million Over Deceptive Risperdal Marketing Claims More...

 

• Tekmira Pharmaceuticals Corporation Files Amended Complaint in Alnylam Pharmaceuticals (ALNY) Litigation More...

• InfoMedics, Inc. Expands in Europe, Latin America and Asia-Pacific More...

• Roche (RHHBY) Melanoma Drug Cuts Risk Of Death By 63 Percent; Bests Bristol-Myers Squibb Company (BMY) In Study More... 

• Pfizer Inc. (PFE)'s Aromasin Blocks Breast Cancer in Healthy, At-Risk Women in Study More... 

• Ariad Pharmaceuticals, Inc. (ARIA) and Merck & Co., Inc. (MRK)'s Cancer Drug for Bones-Tissue Extends Patient Lives in Study More... 

• Pfizer Inc. (PFE) Lung Cancer Pill May Double Survival More... 

• United Therapeutics Corporation (UTHR)'s FREEDOM-M Phase 3 Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint More...

• American Regent, Inc. Initiates Nationwide Voluntary Recall of Methyldopate HCL Injection, USP 5 mL Single Dose Vial Due to Glass Particulates More...

• Incyte Corporation (INCY) Submits New Drug Application for Ruxolitinib in Myelofibrosis to the US FDA More...

• Finally, a Pill for Men 'With No Side-Effects' Which Could be on the Shelves in a Few Years Columbia University Study More... 

• New Generation Asthma Drug Could Improve Metabolism, Garvan Institute of Medical Research Research Suggests More... 

• Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent, Karolinska Institute Study More... 

• Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects More... 

• Ipsen Announces Discontinuation of the Development of Irosustat in Monotherapy More...